Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 27, 2022

SELL
$28.67 - $37.13 $195,185 - $252,781
-6,808 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$28.63 - $35.64 $10,793 - $13,436
-377 Reduced 5.25%
6,808 $223,000
Q2 2021

Jul 15, 2021

BUY
$28.45 - $38.0 $204,413 - $273,030
7,185 New
7,185 $217,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Founders Capital Management, LLC Portfolio

Follow Founders Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.